Sanjivani Paranteral gains on incorporating subsidiary company
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Sanjivani Paranteral is currently trading at Rs. 178.25, up by 2.90 points or 1.65% from its previous closing of Rs. 175.35 on the BSE.
The scrip opened at Rs. 181.00 and has touched a high and low of Rs. 181.00 and Rs. 167.10 respectively. So far 2806 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 187.20 on 02-Jan-2024 and a 52 week low of Rs. 24.80 on 24-Mar-2023.
Last one week high and low of the scrip stood at Rs. 183.00 and Rs. 167.10 respectively. The current market cap of the company is Rs. 203.60 crore.
The promoters holding in the company stood at 32.34%, while Institutions and Non-Institutions held 6.01% and 61.65% respectively.
Sanjivani Paranteral has incorporated subsidiary of the company in the name of ‘SPL Infusion’ on February 27, 2024. The said subsidiary has been incorporated for manufacturing of Pharmaceuticals formulations and medical devices including IV Fluid and IV Sets.
Sanjivani Paranteral is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices.
